Copyright © 2026 Authors retain the copyright of this article. This article is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

@article{171551,
        author = {Pramod Bhaiyyasaheb Thakare and Aniket S. Salunke and Mr.Zahid Anwar and Mr.Tufail Dana and Mr. M.B Nikam},
        title = {Current Trends and Challenges in Quality Assurance and Quality Control in Pharmaceutical Manufacturing: A Comprehensive Analysis.},
        journal = {International Journal of Innovative Research in Technology},
        year = {2024},
        volume = {11},
        number = {8},
        pages = {216-220},
        issn = {2349-6002},
        url = {https://ijirt.org/article?manuscript=171551},
        abstract = {Pharmaceutical manufacturing relies on robust Quality Assurance (QA) and Quality Control (QC) systems to ensure product safety, efficacy, and compliance with stringent regulations. This paper explores current trends, challenges, and future directions in QA/QC, highlighting advancements in automation, data analytics, continuous manufacturing, and regulatory harmonization. It also delves into critical challenges, including regulatory compliance, data integrity, supply chain complexities, and workforce shortages. To address these issues, the industry must adopt innovative technologies, robust risk management strategies, and sustainable practices while fostering a skilled workforce. These efforts are essential for maintaining high-quality standards and ensuring patient safety in a rapidly evolving landscape.},
        keywords = {Pharmaceutical Manufacturing, Quality Assurance (QA), Quality Control (QC), Regulatory Compliance, Data Integrity, Process Analytical Technology (PAT), Continuous Manufacturing, Artificial Intelligence (AI), Machine Learning, Automation, Supply Chain Management, Risk Management, Sustainability},
        month = {December},
        }